The Sift Here’s what we’re Sifting today

FDA changes hydroxychloroquine status

by Rachel Lynn Aldrich
Posted 6/15/20, 05:46 pm

The unproven benefits of two malaria drugs in treating or preventing COVID-19 “do not outweigh the known and potential risks,” the U.S. Food and Drug Administration announced on Monday. The agency pulled its emergency use authorization for dispensing hydroxychloroquine and chloroquine to coronavirus patients, citing reports of heart problems and other complications.

Does that mean doctors can’t use the drugs? The emergency use authorization meant the federal government would distribute its own stockpile of the drugs to state and local health officials to treat the virus. The move limits access to the drug, but doctors can still write off-label prescriptions for COVID-19 patients.

Dig deeper: Read Dr. Charles Horton’s report on how the back-and-forth over possible COVID-19 treatments erodes public trust in health officials.


Read more from The Sift Sign up for The Sift email
Rachel Lynn Aldrich

Rachel is an assistant editor for WORLD Digital. Follow Rachel on Twitter @Rachel_Lynn_A.

Read more from this writer

Comments

You must be a WORLD Member and logged in to the website to comment.
  • NEWS2ME
    Posted: Tue, 06/16/2020 05:21 pm

    We have seen the TV ads what drugs the FDA approves and the KNOWN side effects. 

    They disapprove of this because of Trump. Is there no one out there that Trump can rely on?

  • Nanamiro
    Posted: Thu, 06/25/2020 04:33 pm

    What a shame. It just increases one's distrust of medical organizations when they make health decisions based on political narratives. I heard an interview with a doctor who said all studies showing this drug to be dangerous were giving it to seriously ill patients in later stages of the illness. She said this was ridiculous because it would only be effective if given when the patient is first diagnosed. Then it showed great promise. 

ADVERTISEMENT